The National Institutes of Health (NIH) have established strict guidelines on the proper use and disposal of transgenic animals, plants and other forms of recombinant and synthetic nucleic acids in research. The document entitled NIH Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines) outlines institutional and investigator responsibilities.
All NIH-funded projects involving recombinant and synthetic nucleic acids must comply with NIH Guidelines. As per the NIH Guidelines, all non-NIH funded projects involving recombinant and synthetic nucleic acids conducted at or sponsored by an institution that receives NIH funding must comply with NIH guidelines.
Failure to follow NIH guidelines can result in the suspension, limitation, or termination of NIH funds for all recombinant and synthetic nucleic acids research at the University. In addition, any intentional failure to comply has the potential to be defined as academic misconduct as outlined by University policy.
As an NIH-funded institution, the University of Illinois at Urbana-Champaign has developed both a policy and a protocol, outlined in this fact sheet, through which investigators may obtain institutional authorization to work with recombinant and synthetic nucleic acids. As an investigator working with recombinant and synthetic nucleic acid materials, it is your responsibility to meet these requirements.
It is the policy of the University of Illinois at Urbana-Champaign that all research conducted on the campus or sponsored by the University involving recombrecombinant and synthetic nucleic acids must receive approval from the Institutional Biosafety Committee (IBC) prior to the start of any work. Although some projects will qualify as exempt from the NIH Guidelines, all projects that involve recombinant and synthetic nucleic acidsmust be registered. Research projects will be assessed by the IBC on an individual basis.
You must register your research project with the IBC to initiate the approval process. The Biological Safety Section (BSS) of the Division of Research Safety coordinates project registration. If you have previously registered your project, you are required to update registration information whenever there are changes in the facilities, personnel, and experimental protocols associated with the project.
University Policy requires that recombinant and synthetic nucleic acid materials must be inactivated to prevent any accidental release. Depending upon the material, autoclave treatment, chemical treatment, or incineration may be employed for inactivation. There are no exceptions to this policy without prior notification and approval by the Institutional Biosafety Committee. If you have questions regarding proper disposal, please contact BSS at 333-2755 or via e-mail.
Intra- or inter-facility transfers of recombinant and synthetic nucleic acids and transgenic materials including transgenic animals and transgenic plants are prohibited without the written approval of the IBC.
University policy requires that significant research-related incidents be reported immediately to the Institutional Biosafety Committee via the Biological Safety Section (BSS) of the Division of Research Safety. Such incidents include research-related accidents and illnesses as well as inadvertent release or improper disposal of biohazardous or recombinant and synthetic nucleic acid materials. BSS can be contacted at 333-2755 and via e-mail.